- Docente: Gloria Ravegnini
- Credits: 5
- SSD: BIOS-11/A
- Language: English
- Teaching Mode: In-person learning (entirely or partially)
- Campus: Rimini
- Corso: Single cycle degree programme (LMCU) in Pharmacy (cod. 5987)
-
from Sep 28, 2026 to Nov 09, 2026
Learning outcomes
At the end of the module the student: - knows the structure, production and post-translational processes of recombinant proteins, purification processes and therapeutic targets of biotechnological drugs on the market; - knows the different classes of therapeutic proteins and monoclonal antibodies and their pharmacodynamic and pharmacokinetic profile; - knows the profile of activity, immunogenicity and safety of biotechnological drugs and biosimilars; - knows how to apply the knowledge learned for the conduct of the profession, for the proper conservation and dispensation of biotechnological drugs and to inform and educate patients in their use and monitor the management of appropriateness in their use and the continuity of adherence to drug therapy in chronic therapies.
Course contents
GENETIC ENGINEERING AND RECOMBINANT DNA
MONOCLONAL ANTIBODIES
Oligonucleotides as Drugs Classification of oligonucleotides. Mechanism of action of oligonucleotides.
PHARMACODYNAMICS
PHARMACOKINETICS
CLINICAL USE OF BIOTECHNOLOGICAL DRUGS DRUGS FOR THE CARDIOVASCULAR SYSTEM
DRUGS FOR THE CENTRAL NERVOUS SYSTEM DRUGS FOR THE RESPIRATORY SYSTEM
Safety of biosimilar drugs.
ADVANCED THERAPY: Cells as drugs
GENE THERAPY TARGET THERAPY TARGETED DRUGS IN ONCOLOGY
EPIGENETIC DRUGS CLINICAL USE OF BIOTECHNOLOGICAL DRUGS
DRUGS FOR ONCOLOGY
DRUGS FOR THE IMMUNE SYSTEM
ADVERSE EFFECTS of Biotechnological Drugs
Readings/Bibliography
Specific scientific articles and PPT slides
Teaching methods
Frontal lessons
Students can interact with the Teacher
Assessment methods
Assessment of learning consists in an oral exam which aims to verify and evaluate the achievement of the learning objectives.
The student evaluations takes into account the correctness of the answers, the understanding of the principles learned showed by the student.
In addition, the level of exposure, also in relation to the previous knowledge necessary for the understanding of the specific exam subject will be considered.
The duration of the oral exam is on average 20-30 minutes. Application on Almaesami
With regard to assessment, the use of artificial intelligence (AI) is prohibited. Any use constitutes a violation of academic integrity.
Teaching tools
PC, Projector. PowerPoint; the slides used during lessons will be available on the VIRTUALE platform.
Students with Specific Learning Disorders (SLD) or temporary or permanent disabilities are encouraged to contact the University's relevant support office as early as possible (https://site.unibo.it/studenti-con-disabilita-e-dsa/it ). The office will propose any appropriate accommodations for eligible students. Such accommodations must be submitted to the course instructor for approval at least 15 days in advance. The instructor will assess their suitability, taking into account the learning objectives of the course.
Office hours
See the website of Gloria Ravegnini